Effect of Oxycodone on Anxiety State in Painless Abortion
Launched by RUIJIN HOSPITAL · May 24, 2024
Trial Information
Current as of February 08, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This study is a multicenter, randomized controlled clinical study. A total of 300 patients who underwent elective painless abortion surgery in Ruijin Hospital and other sub-central hospitals were enrolled, and they were randomly divided into 1:1 patients who received intravenous anesthesia with propofol with fentanyl (group F) and propofol with oxycodone (group O). The scores of anxiety, depression and postoperative numerical rating scale (NRS) before and after surgery were observed, and the levels of serum stress response factors and inflammatory cytokines were monitored. The effects of ox...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Age 18-45 years old
- • Gestational age 6-12 weeks
- • American Society of Anesthesiologists (ASA) Grading I-II
- • Fluent communicator and able to complete self-rating scales on her own
- • Voluntarily participate and sign the informed consent form
- Exclusion Criteria:
- • Patients who are allergic to anesthetic drugs such as propofol, oxycodone, fentanyl, etc., or who have had other anesthetic adverse events
- • Patients with anxiety or depression
- • Presence of organic mental disorders, mental retardation
- • Severe acute and chronic infection, severe heart, liver and kidney insufficiency
- • Patients with complications or bleeding \> 50ml during surgery
About Ruijin Hospital
Ruijin Hospital, affiliated with Shanghai Jiao Tong University School of Medicine, is a leading medical institution in China recognized for its commitment to advancing healthcare through innovative research and clinical trials. With a strong emphasis on patient-centered care, Ruijin Hospital integrates cutting-edge medical practices with rigorous scientific investigation. The hospital's multidisciplinary teams are dedicated to developing new therapeutic approaches, improving patient outcomes, and contributing to global medical knowledge. As a sponsor of clinical trials, Ruijin Hospital ensures adherence to the highest ethical standards and regulatory compliance, fostering an environment of collaboration and excellence in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0